$SKAS
Saker Aviation Services, Inc.

2024 Q2 Form 10-K Financial Statement

#000143774924010272 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $2.623M $2.519M $8.838M
YoY Change 8.77% 35.86% 16.31%
Cost Of Revenue $1.231M $680.0K $2.556M
YoY Change 92.96% -3.12% -14.37%
Gross Profit $1.392M $1.839M $6.281M
YoY Change -21.53% 59.59% 36.15%
Gross Profit Margin 53.06% 73.01% 71.07%
Selling, General & Admin $496.0K $738.3K $2.768M
YoY Change -38.72% -24.03% -28.67%
% of Gross Profit 35.64% 40.14% 44.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.880K $3.870K $16.00K
YoY Change -7.84% -455.05% -84.01%
% of Gross Profit 0.28% 0.21% 0.25%
Operating Expenses $496.0K $738.3K $2.768M
YoY Change -38.72% -24.03% -28.67%
Operating Profit $895.7K $1.101M $3.513M
YoY Change -7.09% 509.43% 379.63%
Interest Expense $108.2K $85.33K $228.6K
YoY Change 70.77% 2485.76% 6826.67%
% of Operating Profit 12.08% 7.75% 6.51%
Other Income/Expense, Net -$946.0K $0.00 $440.6K
YoY Change -1593.23% -29.88%
Pretax Income -$50.31K $1.186M $3.953M
YoY Change -104.9% 544.88% 190.54%
Income Tax $19.00K $504.0K $1.507M
% Of Pretax Income 42.49% 38.12%
Net Earnings -$31.31K $682.2K $2.446M
YoY Change -104.52% 99.1% 96.25%
Net Earnings / Revenue -1.19% 27.08% 27.68%
Basic Earnings Per Share -$0.03 $2.50
Diluted Earnings Per Share -$0.03 $0.70 $2.47
COMMON SHARES
Basic Shares Outstanding 985.9K 976.3K 976.8K
Diluted Shares Outstanding 1.025M 989.7K

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.498M $9.475M $9.475M
YoY Change 42.44% 58.52% 58.52%
Cash & Equivalents $6.034M $6.932M
Short-Term Investments $3.463M $2.543M $2.543M
Other Short-Term Assets $799.2K $745.6K $745.6K
YoY Change 231.66% 110.08% 110.08%
Inventory $8.739K $1.142K $1.140K
Prepaid Expenses $799.2K $745.6K
Receivables $253.9K $294.5K $294.5K
Other Receivables $0.00 $44.90K $44.90K
Total Short-Term Assets $10.56M $10.56M $10.56M
YoY Change 42.8% 53.73% 53.73%
LONG-TERM ASSETS
Property, Plant & Equipment $43.85K $49.44K $49.44K
YoY Change 27.37% 15.35% 15.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $43.85K $49.44K $49.44K
YoY Change 27.37% 15.35% 15.33%
TOTAL ASSETS
Total Short-Term Assets $10.56M $10.56M $10.56M
Total Long-Term Assets $43.85K $49.44K $49.44K
Total Assets $10.60M $10.61M $10.61M
YoY Change 42.73% 53.49% 53.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.618M $705.1K $705.1K
YoY Change 210.71% 114.65% 114.64%
Accrued Expenses $201.7K $1.333M $1.333M
YoY Change -27.59% 123.2% 123.2%
Deferred Revenue $258.3K $253.4K
YoY Change 26.23% 23.85%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.078M $2.292M $2.292M
YoY Change 106.98% 102.73% 102.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.078M $2.292M $2.292M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.078M $2.292M $2.292M
YoY Change 106.98% 102.73% 102.73%
SHAREHOLDERS EQUITY
Retained Earnings -$11.46M -$11.61M
YoY Change -14.93% -17.4%
Common Stock $19.98M $19.93M
YoY Change 0.45% 0.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.526M $8.319M $8.319M
YoY Change
Total Liabilities & Shareholders Equity $10.60M $10.61M $10.61M
YoY Change 42.73% 53.49% 53.49%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$31.31K $682.2K $2.446M
YoY Change -104.52% 99.1% 96.25%
Depreciation, Depletion And Amortization $3.880K $3.870K $16.00K
YoY Change -7.84% -455.05% -84.01%
Cash From Operating Activities -$183.9K $715.3K $3.344M
YoY Change -135.45% -217.51% 95.29%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $22.99K
YoY Change -100.0% 46.59%
Acquisitions
YoY Change
Other Investing Activities $16.02K $59.01K -$2.367M
YoY Change -95.9% -264.36%
Cash From Investing Activities $16.02K $59.01K -$2.390M
YoY Change -95.88% -267.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $0.00
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -183.9K 715.3K $3.344M
Cash From Investing Activities 16.02K 59.01K -$2.390M
Cash From Financing Activities 0.000 $0.00
Net Change In Cash -167.9K 774.3K $954.6K
YoY Change -132.36% -38.67% -72.96%
FREE CASH FLOW
Cash From Operating Activities -$183.9K $715.3K $3.344M
Capital Expenditures $0.00 $0.00 $22.99K
Free Cash Flow -$183.9K $715.3K $3.321M
YoY Change -135.45% -216.36% 95.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Assets
Assets
6912925 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
328505 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
204633 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
597262 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-212000 usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001128281
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023 skas Sharebased Compensation Weighted Average Remaining Amortization Period
SharebasedCompensationWeightedAverageRemainingAmortizationPeriod
P5Y
CY2023Q3 skas Interim Agreement Renewal Period
InterimAgreementRenewalPeriod
P6Y
CY2023Q3 skas Interim Agreement Initial Term
InterimAgreementInitialTerm
P6Y
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.03 par value
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
3180693 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
985888
CY2023 dei Auditor Name
AuditorName
Kronick Kalada Berdy & Co. P.C.
CY2023 dei Auditor Location
AuditorLocation
Kingston, Pennsylvania
CY2023 dei Auditor Firm
AuditorFirmId
448
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6931709 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5977157 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
2543321 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
294521 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
244543 usd
CY2023Q4 skas Noncomplete Receivables Current
NoncompleteReceivablesCurrent
0 usd
CY2022Q4 skas Noncomplete Receivables Current
NoncompleteReceivablesCurrent
160000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1142 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
13551 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
44899 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
119899 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
745606 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
354913 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10561198 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6870063 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3127876 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3111462 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49440 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42862 usd
CY2023Q4 us-gaap Assets
Assets
10610638 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
705133 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
253446 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1333092 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2291671 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1130400 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2291671 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1130400 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.03
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.03
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
985888
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
985888
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
976330
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
976330
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
29577 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
29290 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19902505 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19812794 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11613115 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14059559 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8318967 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5782525 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10610638 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6912925 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8837614 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7598597 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2556394 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2985281 usd
CY2023 us-gaap Gross Profit
GrossProfit
6281220 usd
CY2022 us-gaap Gross Profit
GrossProfit
4613316 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2768310 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3880902 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-125000 usd
CY2023 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
0 usd
CY2022 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
500000 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
8479 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
440577 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
628302 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3953487 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1360716 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1507043 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2446444 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1060716 usd
CY2023 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
0 usd
CY2022 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
-65413 usd
CY2023 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 usd
CY2022 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
431318 usd
CY2023 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-0 usd
CY2022 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
180000 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
185905 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1246621 usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.47
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976782
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976048
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
989686
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
987149
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4463909 usd
CY2022 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
71995 usd
CY2022 skas Adjustment To Additional Paid In Capital Issuance Of Additional Common Stock
AdjustmentToAdditionalPaidInCapitalIssuanceOfAdditionalCommonStock
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1246621 usd
CY2023 skas Adjustment To Additional Paid In Capital Issuance Of Additional Common Stock
AdjustmentToAdditionalPaidInCapitalIssuanceOfAdditionalCommonStock
-7999 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2446444 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8318967 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2446444 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1246621 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16414 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100089 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
17979 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
728110 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
216546 usd
CY2023 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
-0 usd
CY2022 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
500000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
81999 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
71995 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
8479 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-0 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
431318 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
49978 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-60866 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12409 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7091 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-75000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-573679 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
390693 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-150805 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
48813 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
123755 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
376628 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
116284 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
735830 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
192689 usd
CY2023 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
897943 usd
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
465935 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3344387 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1712556 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3386842 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
CY2023 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
852000 usd
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
CY2023 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1440000 usd
CY2023 skas Payments For Exercise Of Stock Options
PaymentsForExerciseOfStockOptions
-7999 usd
CY2022 skas Payments For Exercise Of Stock Options
PaymentsForExerciseOfStockOptions
-0 usd
CY2023 skas Payments Of Notes Receivable From Sale Of Assets
PaymentsOfNotesReceivableFromSaleOfAssets
-160000 usd
CY2022 skas Payments Of Notes Receivable From Sale Of Assets
PaymentsOfNotesReceivableFromSaleOfAssets
-0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22992 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15685 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2389835 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1424315 usd
CY2023 skas Proceeds From Life Insurance Policy Classified As Financing Activities
ProceedsFromLifeInsurancePolicyClassifiedAsFinancingActivities
0 usd
CY2022 skas Proceeds From Life Insurance Policy Classified As Financing Activities
ProceedsFromLifeInsurancePolicyClassifiedAsFinancingActivities
500000 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
67045 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
-0 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
39575 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
393380 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
954552 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3530251 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5977157 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2446906 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6931709 usd
CY2023 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2022 us-gaap Notes Issued1
NotesIssued1
160000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6931709 usd
CY2023Q4 skas Working Capital
WorkingCapital
8269527 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8837614 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2446444 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2446444 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3344387 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2389835 usd
CY2023 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
40000 usd
CY2023Q3 skas Amount Of Gross Receipts During Initial Term
AmountOfGrossReceiptsDuringInitialTerm
1036811 usd
CY2023Q3 skas Percentage Of Gross Receipts During Initial Term
PercentageOfGrossReceiptsDuringInitialTerm
0.30 pure
CY2023Q3 skas Amount Of Gross Receipts During Both Renewal Periods
AmountOfGrossReceiptsDuringBothRenewalPeriods
518406 usd
CY2023Q4 skas Percentage Amount Of Gross Receipts During Both Renewal Periods
PercentageAmountOfGrossReceiptsDuringBothRenewalPeriods
0.30 pure
CY2023 skas Concession Fees
ConcessionFees
682000 usd
CY2022 skas Concession Fees
ConcessionFees
1509000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include depreciation, amortization, stock-based compensation, allowance for credit losses, deferred tax assets, and contingent liabilities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3111462 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
253446 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
204633 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976782
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976048
CY2023 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
12904
CY2022 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
11101
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
989686
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
987149
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13332
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26664
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
81999 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
71995 usd
CY2023 skas Shares Based Compensation Stock Options Unamortized Fair Value
SharesBasedCompensationStockOptionsUnamortizedFairValue
92880 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.04918 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.04918 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0384 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0399 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3177316 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3154324 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3127876 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49440 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42862 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
86000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
86000 usd
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
376000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
385000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
462000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
471000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
462000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
471000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-9000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
-0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
0.117 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.17 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.127 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22 pure
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
976330
CY2023 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
9558
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
985888
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59994
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.184
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20832
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.9
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3333
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.58
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9999
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.24
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
67494
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.04
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13332
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.6
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13332
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.662
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
67494
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.012
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
67494
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
54162
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
74080 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306

Files In Submission

Name View Source Status
0001437749-24-010272-index-headers.html Edgar Link pending
0001437749-24-010272-index.html Edgar Link pending
0001437749-24-010272.txt Edgar Link pending
0001437749-24-010272-xbrl.zip Edgar Link pending
ex_643851.htm Edgar Link pending
ex_643852.htm Edgar Link pending
ex_643853.htm Edgar Link pending
ex_643854.htm Edgar Link pending
ex_643983.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skas-20231231.xsd Edgar Link pending
skas20231231_10k.htm Edgar Link pending
skas-20231231_def.xml Edgar Link unprocessable
skas-20231231_lab.xml Edgar Link unprocessable
skas-20231231_pre.xml Edgar Link unprocessable
skas20231231_10k_htm.xml Edgar Link completed
skas-20231231_cal.xml Edgar Link unprocessable